Table 2 Laboratory and clinical parameters in patients and controls
Control group (A) | Patient group (B) | Test value | P value | |
|---|---|---|---|---|
Bilirubin | ||||
Median (IQR) | 0.7 (0.45–0.9) | 2.4 (2.1–3.15) | 7.323 | <0.001 |
Range | 0.3–0.8 | 1.6–3.9 | ||
Albumin | ||||
Mean±SD | 4.24 ± 0.35 | 2.83 ± 0.44 | 0.812 | <0.001 |
Range | 3.6–4.9 | 1.9–3.7 | ||
Sodium | ||||
Mean±SD | 140 ±3 | 131 ± 3 | 14.380 | 0.35 |
Range | 136–145 | 126–136 | ||
Potassium | ||||
Mean±SD | 4.1 ± 0.4 | 3.7 ± 0.4 | 5.146 | 0.89 |
Range | 3.5–4.8 | 3.2–4.4 | ||
INR | ||||
Mean±SD | 1.06 ± 0.06 | 2.03 ± 0.35 | 50.727 | <0.001 |
Range | 1–1.2 | 1.4–3 | ||
Encephalopathy | ||||
No | 40 (100.0%) | 15 (37.5%) | 36.364 | <0.001 |
Grade I | 0 (0.0%) | 16 (40.0%) | ||
Grade II | 0 (0.0%) | 5 (12.5%) | ||
Grade III | 0 (0.0%) | 4 (10.0%) | ||
Ascites | ||||
No | 40 (100.0%) | 4 (10.0%) | 65.455 | <0.001 |
Mild | 0 (0.0%) | 14 (35.0%) | ||
Moderate | 0 (0.0%) | 14 (35.0%) | ||
Tense | 0 (0.0%) | 8(20.0%) | ||
Child | ||||
Control | 40 (100.0%) | 0 (0.0%) | 80.000 | <0.001 |
Child B | 0 (0.0%) | 18 (45.0%) | ||
Child C | 0 (0.0%) | 22 (55.0%) | ||